Related Experiment Video
Updated: Sep 29, 2026

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG
Published on: December 28, 2014
Effects of cerebral ischemia on regional dopamine release and D1 and D2 receptors
C J Chang1, H Ishii, H Yamamoto
1Stroke Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892.
Abstract:
To expand on the nature of regional cerebral vulnerability to ischemia, the release of dopamine (DA) and dopaminergic (D1 and D2) receptors were investigated in Mongolian gerbils subjected to bilateral carotid artery occlusion (15 min) alone or with reflow (1-2 h). Extracellular cortical and striatal content of DA and its metabolites was measured by microdialysis using HPLC with electrochemical detection. The kinetic properties of D1 and/or D2 receptor binding sites were determined in cortical and striatal membranes with the use of radiolabeled ligands (125I-SCH23982 and [3H]YM-09151-2, respectively). The ischemic release of DA from the striatum was greater (400-fold over preischemic level) than that from the cortex (12-fold over preischemic content). The affinity for the D1-receptor ligand was lower (KD = 1.248 +/- 0.047 nM) after ischemia than that for sham controls (KD = 0.928 +/- 0.032 nM, p < 0.001). The number of binding sites for D2 receptors decreased in striatum (Bmax = 428 +/- 18.4 fmol/mg of protein) after ischemia compared with sham controls (Bmax = 510 +/- 25.2 fmol/mg of protein, p < 0.05). D1 or D2 binding sites were not changed either in the ischemic cortex or postischemic striatum and cortex. The findings strongly suggest that the ischemic release of DA from striatum is associated with early transient changes in D1- and D2-mediated DA neurotransmission.
Insights
Ischemia significantly increases dopamine release in the striatum and cortex of gerbils. This ischemic event alters dopamine receptor binding, affecting neurotransmission.
Area of Science:
- Neuroscience
- Cerebrovascular Research
- Neurochemistry
Background:
- Regional cerebral vulnerability to ischemia is not fully understood.
- Dopamine (DA) neurotransmission plays a role in brain function and may be affected by ischemic events.
Purpose of the Study:
- To investigate the release of dopamine and the characteristics of dopaminergic receptors in response to ischemia.
- To explore regional differences in cerebral vulnerability to ischemia.
Main Methods:
- Mongolian gerbils underwent transient bilateral carotid artery occlusion.
- Extracellular dopamine and metabolite levels were measured using microdialysis and HPLC.
- Dopamine D1 and D2 receptor binding kinetics were assessed using radiolabeled ligands.
Main Results:
- Striatal dopamine release was significantly higher (400-fold) than cortical release (12-fold) during ischemia.
- Ischemia decreased D1 receptor affinity in the cortex and reduced D2 receptor binding sites in the striatum.
- No significant changes in D1 or D2 receptor binding were observed in the ischemic cortex or post-ischemic striatum/cortex.
Conclusions:
- Striatal dopamine release is markedly elevated during ischemia.
- Early, transient alterations in D1 and D2 receptor-mediated dopamine neurotransmission occur in the striatum following ischemia.
- These findings suggest a role for dopamine system changes in regional cerebral vulnerability to ischemic injury.
More Related Videos
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology